- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/425 - Thiazoles
Patent holdings for IPC class A61K 31/425
Total number of patents in this class: 1005
10-year publication summary
|
59
|
34
|
30
|
43
|
35
|
26
|
30
|
16
|
31
|
31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2191 |
16 |
| Bristol-myers Squibb Company | 4881 |
14 |
| Abbvie Inc. | 1799 |
12 |
| Allergan, Inc. | 2340 |
11 |
| Janssen Pharmaceutica N.V. | 3377 |
10 |
| F. Hoffmann-La Roche AG | 7945 |
9 |
| The Regents of the University of California | 19989 |
9 |
| Vertex Pharmaceuticals Incorporated | 1602 |
9 |
| PanOptica, Inc. | 11 |
9 |
| Romark Laboratories L.C. | 52 |
9 |
| EyePoint Pharmaceuticals, Inc. | 101 |
9 |
| Nutrition & Biosciences USA 2, LLC | 80 |
9 |
| Novartis AG | 10741 |
8 |
| Boehringer Ingelheim International GmbH | 4641 |
8 |
| Glaxosmithkline LLC | 537 |
7 |
| Melior Pharmaceuticals I, Inc. | 25 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2574 |
6 |
| Eli Lilly and Company | 3855 |
6 |
| Knopp Biosciences LLC | 27 |
6 |
| Takeda Pharmaceutical Company Limited | 2711 |
5 |
| Other owners | 826 |